The Massachusetts Medical Society and its Committee on Maternal and Perinatal Welfare voiced their support of the FDA’s decision to permit sales of over-the-counter progestin-only birth control, according to a July 18 news release.
Read the full post on Becker's Hospital Review - Healthcare News
